🟢 Cerenome is trading 5.7% up in pre-market — catalyst remains unclear

Cerenome is trading at $1.85, up +5.71%, with no confirmed catalyst for the pre-market move.

• No fresh company announcement dated October 23, 2026, was identified; Cerenome’s latest listed release was October 21, covering preclinical REYOBIQ data.
• The broader backdrop is risk-off, with major U.S. indices modestly lower, but that does not clearly explain the stock’s pre-market gain.
• The cause of the move remains unclear.